Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth

Authors

Neeleesh R. Soman, Washington University School of Medicine in St. Louis
Steven L. Baldwin, Washington University School of Medicine in St. Louis
Grace Hu, Washington University School of Medicine in St. Louis
Jon N. Marsh, Washington University School of Medicine in St. Louis
Gregory M. Lanza, Washington University School of Medicine in St. Louis
John E. Heuser, Washington University School of Medicine in St. Louis
Jeffrey M. Arbeit, Washington University School of Medicine in St. Louis
Samuel A. Wickline, Washington University School of Medicine in St. Louis
Paul H. Schlesinger, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2009

Volume

119

Issue

9

Inclusive Pages

2830-2842

Document Type

Open Access Publication

DOI

10.1172/JCI38842

Rights and Permissions

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth Neelesh R. Soman, Steven L. Baldwin, Grace Hu, Jon N. Marsh, Gregory M. Lanza, John E. Heuser, Jeffrey M. Arbeit, Samuel A. Wickline, Paul H. Schlesinger Published in Volume 119, Issue 9 J Clin Invest. 2009; 119(9):2830–2842 doi:10.1172/JCI38842

Recommended Citation

Soman, Neeleesh R.; Baldwin, Steven L.; Hu, Grace; Marsh, Jon N.; Lanza, Gregory M.; Heuser, John E.; Arbeit, Jeffrey M.; Wickline, Samuel A.; and Schlesinger, Paul H., "Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth." The Journal of Clinical Investigation. 119, 9. 2830-2842. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/1627